SCHEMBL9518019

SCHEMBL9518019

O=CC(c1ccc(F)cc1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
P4HTM Q9NXG6 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
EPHX2 P34913 3/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP2J2 P51589 1/20 0.38
CASP3 P42574 4/20 0.37
PTGS2 P35354 2/20 0.36
PTGS1 P23219 1/20 0.35
CXCR1 P25024 2/20 0.35
CXCR2 P25025 2/20 0.35
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516974 0.89 EGFR (0.44) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515768 0.88 HIF1A (0.40) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9517025 0.87 CASP3 (0.39) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9517908 0.86 CXCR1 (0.39) P4HTMHDAC6HDAC3HDAC1HDAC2
SCHEMBL9515607 0.86 EPHX2 (0.40) P4HTMHDAC6HDAC3HDAC1HDAC2
SCHEMBL9515835 0.85 LMNA (0.39) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515632 0.85 MEN1 (0.38) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515748 0.84 P4HTM (0.39) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9516883 0.83 MMP1 (0.39) KMT2AP4HTM
SCHEMBL9517088 0.83 CXCR2 (0.38) KMT2AP4HTMEPHX2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed